Status:
UNKNOWN
Impact of Hyperuricemia on Psoriatic Arthritis
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Psoriatic arthritis and gout (linked to hyperuricemia) are two rheumatisms well known to rheumatologists. There are epidemiological and physiopathological arguments in favor of a non-fortuitous link b...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Major subject (≥18 years old)
- Subject with a history of psoriatic arthritis objectified according to the CIM 10-1 coding for patients followed in hospitalization at the HUS and HCC
- Subject presenting psoriatic arthritis objectified during a consultation by an HCC rheumatologist
- Among these two populations, all subjects for whom at least one serum uric acid assay was available in the medical file
- Subject having not expressed, after being informed, opposition to the reuse of their data for research purposes
- Exclusion criteria:
- Subject who expressed their opposition to participating in the study
- Subject who met the inclusion criteria but whose analysis of the medical file (anamnestic, clinical, biological and radiological data) led to a diagnostic reversal and therefore did not present with psoriatic arthritis
- Subject under guardianship or curatorship
- Subject under safeguard of justice
Exclusion
Key Trial Info
Start Date :
August 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT06125444
Start Date
August 24 2020
End Date
December 31 2023
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Rhumatologie - CHU de Strasbourg - France
Strasbourg, France, 67091